Archives of Academic Emergency Medicine. 2019; 7 (1): e37 OR I G I N A L RE S E A RC H Pro-Calcitonin, Erythrocyte Sedimentation Rate and C - reactive Protein in Predicting Diabetic Foot Ulcer Charac- teristics; a Cross Sectional Study Fahimeh Hadavand1, Atefeh Amouzegar2, Hessam Amid1∗ 1. Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 2. Department of Nephrology, Firoozgar Clinical Research Development Center (FCRDC), Iran University of Medical Sciences, Tehran, Iran. Received: February 2019; Accepted: June 2019; Published online: 10 July 2019 Abstract: Introduction: Considering the importance of early diagnosis of diabetic foot ulcers and its complications, this study aimed to evaluate the accuracy of erythrocyte sedimentation rate (ESR), C - reactive protein (CRP), and pro-calcitonin (PCT) in predicting the ulcer class, osteomyelitis, and peripheral arterial disease (PAD). Methods: This cross-sectional study was performed on 200 consecutive patients suffering from diabetic foot ulcer who were referred to Infectious Disease Ward. The levels of PCT, ESR, and CRP were measured for all patients and the screening performance characteristics of each marker in predicting the ulcer class, osteomyelitis, and PAD was calculated. Results: The levels of PCT, ESR and CRP were significantly higher in patients with class IV foot ulcer compared to those with class III ulcers (p<0.001). Patients with evidence of osteomyelitis had significantly higher level of PCT, ESR and CRP. The best cutoff points of PCT, ESR and CRP in predicting osteomyelitis were 0.35 ng/ml (86.1% sensitivity, 45.3% specificity), 56.5 mm/hours (95.8% sensitivity, and 50.0% specificity) and 44 mg/ml (90.3% sensitivity, 57.0% specificity), respectively. The presence of PAD was significantly associated with increased levels of the three biomarkers. The best cutoff values for PCT, ESR and CRP in predicting PAD were 0.45 (70.8% sensitivity, 71.7% specificity), 61.5 (83.3% sensitivity, 52.0% specificity) and 49 (83.3% sensitivity, 63.8% specificity), respectively. Conclusion: Based on the findings of the present study, although the accuracy of PCT, ESR, and CRP in predicting the severity of diabetic foot ulcers was fair, increase in the three parameters can predict the occurrence of osteomyelitis and PAD following diabetic food development with good accuracy and acceptable sensitivity. Keywords: blood sedimentation; procalcitonin; diabetic foot; peripheral arterial disease Cite this article as: Hadavand F, Amouzegar A, Amid H. Pro-Calcitonin, Erythrocyte Sedimentation Rate and C - reactive Protein in Predicting Diabetic Foot Ulcer Characteristics; a Cross Sectional Study. Arch Acad Emerg Med. 2019; 7(1): e37. 1. Introduction Diabetes and its complications have affected a large num- ber of people around the world, with an estimated increased worldwide prevalence in all age groups from 2.8% in 2000 to 4.4% in 2030 (1). Despite the medical and surgical ad- vances in the last decade, problems with diabetic foot, which is one of the most important chronic complications of dia- betes, remain a health problem and is the most important cause of non-traumatic foot injuries (2). The likelihood of a ∗Corresponding Author: Hessam Amid; Infectious Diseases and Tropi- cal Medicine Research Center, Shahid Beheshti University of Medical Sci- ences, 7th floor, Tehran, Iran. Postal code: 1985717443 Email: drhe- samamid66@yahoo.com Tel: 00982122672493 diabetic patient developing foot lesions (ulcer / gangrene) is estimated to be 15-25 percent throughout life, with an annual incidence of 1 to 4.1 percent, more than 15 percent of which ultimately results in amputation of the organ. Some risk fac- tors of diabetic foot ulcers are as follow: having had diabetes for over 10 years, male gender, uncontrolled blood sugar, and cardiovascular, renal and ocular diseases (2). Another impor- tant issue in patients with diabetic foot ulcers is the high sus- ceptibility of these ulcers to severe inflammation and wound infections. Patients with diabetes mellitus are prone to se- vere foot infection due to neuropathy and vascular dysfunc- tion (3). It is difficult to determine severity of diabetic foot ulcer and to distinguish non-infectious and infectious wounds in the early stages (4). When clinical symptoms are misleading, lab- This open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0). Downloaded from: http://journals.sbmu.ac.ir/aaem F. Hadavand et al. 2 oratory tests can help determine disease severity and also di- agnose the foot ulcer infection. Many studies have focused on the role of inflammatory markers such as erythrocyte sed- imentation rate (ESR) and C - reactive protein (CRP), as well as pro-calcitonin (PCT) to predict the onset of inflamma- tion and infection, especially in bacterial involvement of dia- betic wounds (5-8). In addition, the diagnostic and predictive values of some circulating inflammatory parameters such as leukocyte counts and circulating inflammatory proteins are evaluated (9, 10). PCT is a protein precursor of calcitonin hormone, which is synthesized and secreted by the C-cells in the thyroid gland. PCT production has been proven to occur after activation of inflammatory cascade by the liver and mononuclear cells and is modulated through cytokines associated with sepsis (11). PCT has also been shown to play a major role in diag- nosis of diabetic foot ulcers, and its role can be even more important than CRP (12-14). Based on above-mentioned points, this study aimed to evaluate the value of PCT, ESR, and CRP in predicting the ulcer class, as well as presence or absence of osteomyelitis and peripheral arterial disease (PAD). 2. Methods 2.1. Study design and setting This cross-sectional study was performed on 200 consecu- tive patients suffering from diabetic foot ulcer who were re- ferred to Infectious Disease ward of Imam Hussein Hospital, Tehran, Iran, from January 2017 to September 2018. The lev- els of PCT ESR, and CRP were measured for all patients and the screening performance characteristics of each marker in predicting the ulcer class, osteomyelitis, and PAD was calcu- lated. Informed consent was obtained from each patient and the study protocol as approved by the ethics committee of Shahid Beheshti University of Medical Sciences (Ethics code: IR.SBMU.MSP.REC.1396.844) 2.2. Participants Adult (age > 18 years) diabetic patients with foot infection, who were hospitalized in the mentioned hospital were in- cluded. Patients with septic shock, unstable hemodynamics or without consent to participate in the study were excluded. 2.3. Data gathering The baseline characteristics including demographics, medi- cal history, comorbidities, duration of diabetes, and the pres- ence of underlying immunodeficiency or using immuno- suppressive medication were collected by reviewing the pa- tients’ profiles. Baseline levels of laboratory biomarkers were also measured and documented for all patients at the time of admission to infectious disease ward. Serum PCT was measured using an enzyme-linked fluorescence assay and its concentration was measured using routine immunoas- say (BRAHMS PCT KRYPTOR system, BRAHMS, Hennigsdorf, Germany). CRP concentration was measured with routine immunoas- say (bionic, America). The sensitivity of the assay and the tar- get value of the calibrator have been standardized against the reference material ERM-DA 472/IFCC. ESR was measured us- ing a closed automated method, using a highly sensitive as- say. An infectious disease resident was responsible for data gath- ering. 2.4. Definitions The severity of diabetic foot was classified according to the Perfusion, Extent, Depth, Infection, Sensation (PEDIS) clas- sification system (15). Based on this classification diabetic ulcers are classified as uninfected (grade 1), mild (grade 2), moderate (grade 3), and severe (grade 4). Mild ulcers: presence of >2 manifestations of inflammation (purulence, pain, warmth) Moderate ulcers: cellulitis extending >2 cm and involvement of muscle, tendon, joint Severe ulcers: infection with systemic toxicity (fever, tachy- cardia, hypotension, etc.) Osteomyelitis was diagnosed using magnetic resonance imaging (MRI) findings. Diabetic foot ulcers were diagnosed based on the clinical manifestation. PAD was verified based on the ankle brachial index (ABI < 1.2). 2.5. Statistical analysis Descriptive analysis was used to describe the data, includ- ing mean ± standard deviation (SD) for quantitative vari- ables and frequency (percentage) for categorical variables. Chi square test, independent t test and Mann-Whitney U test were used for comparison of variables. The correlation between quantitative variables was tested by the Pearson’s correlation test. The receiver operating characteristic (ROC) curve analysis was used to assess the value of biomarkers in predicting the studied endpoints. For statistical analysis, the statistical software IBM SPSS Statistics for Windows version 22.0 (IBM Corp. Released 2013, Armonk, New York) was used. P values <0.05 were considered statistically significant. 3. Results 3.1. Baseline characteristics of studied patients 200 patients with the mean age of 61.26 ± 11.32 (33 -87) years were included (71.5% male). According to the PEDIS classi- This open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0). Downloaded from: http://journals.sbmu.ac.ir/aaem 3 Archives of Academic Emergency Medicine. 2019; 7 (1): e37 Figure 1: Area under the receiver operating characteristic (ROC) curve of pro-calcitonin (PCT), erythrocyte sedimentation rate (ESR), and C - reactive protein (CRP) in predicting the ulcer class, osteomyelitis, and peripheral arterial disease (PAD). Table 1: Mean pro-calcitonin (PCT), erythrocyte sedimentation rate (ESR), and C - reactive protein (CRP) measures based on ulcer class and presence or absence of osteomyelitis and peripheral arterial disease (PAD) Index PCT P CRP P ESR P Ulcer class III 0.39 ± 0.17 <0.001 43.84 ± 24.01 <0.001 59.30 ± 19.81 <0.001 IV 0.63 ± 0.59 56.96 ±30.22 73.00 ± 21.79 Osteomyelitis Absent 0.38 ± 0.17 <0.001 39.35 ± 17.87 <0.001 55.73 ± 15.54 <0.001 Present 0.77 ± 0.69 71.86 ± 31.42 86.57 ± 17.41 PAD Absent 0.47 ± 0.48 <0.001 43.68 ± 20.10 <0.001 61.36 ± 19.36 <0.001 Present 0.69 ± 0.39 74.40 ± 36.93 84.17 ± 20.86 Data are presented as mean ± standard deviation. fication, 45.0% were class III and 55.0% had class IV of dia- betic foot ulcer. The mean duration of suffering from dia- betes was 11.79 ± 3.94 years. 13.0% were immune-deficient all of whom used immunosuppressive medications. Accord- ing to the MRI findings, the evidence of osteomyelitis was found in 36.0%. Mean hemoglobin A1C was 7.91 ± 1.81% ad it ranged from 4.7 to 18.3. Mean ABI was 1.02 ± 0.22 and 24.0% suffered from PAD with ABI less than 0.9. Regarding labora- tory parameters, mean CRP was 51.05 ± 28.30 mg/ml, mean PCT was 0.52 ± 0.47 ng/ml and mean ESR was 66.84 ± 21.96 mm/hr. There was a significant correlation between PCT and ESR (r = 0.395, p < 0.001) as well as PCT and CRP (r = 0.334, p < 0.001). 3.2. Prediction of ulcer class The level of PCT, ESR and CRP were significantly higher in patients with class IV foot ulcer compared to those with class III (p<0.001, table 1). As summarized in table 2 and figure 1, ESR, CRP and PCT had moderate value for predicting class of diabetic foot ulcer according to ROC analysis. 3.3. Prediction of osteomyelitis Patients with the evidence of osteomyelitis had significantly higher levels of PCT, ESR and CRP (table 1). The areas under the ROC curve of PCT, ESR and CRP in predicting osteomyeli- tis were 0.787, 0.869, and 0.907, respectively; showing high predictive value for each biomarker (table 2, figure 1). The best cutoff points and yielded sensitivity and sensitivity of PCT, ESR and CRP at that points in predicting osteomyeli- tis were 0.35 ng/ml (sensitivity of 86.1% and specificity of 45.3%), 56.5 mm/hours (sensitivity of 95.8% and specificity of 50.0%) and 44 mg/ml (sensitivity of 90.3% and specificity of 57.0%), respectively. 3.4. Prediction of PAD The presence of PAD was significantly associated with in- creased levels of the three biomarkers. The areas under the ROC curve of PCT, ESR and CRP in predicting PAD were 0.733, 0.807 and 0.789, respectively (table 2, figure 1). The best cut- This open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0). Downloaded from: http://journals.sbmu.ac.ir/aaem F. Hadavand et al. 4 Table 2: Screening performance characteristics of pro-calcitonin (PCT), erythrocyte sedimentation rate (ESR), and C - reactive protein (CRP) in predicting ulcer class, osteomyelitis, and peripheral arterial disease (PAD) Index AUC sensitivity specificity PPV NPV Ulcer class PCT 0.68 (0.60-0.75) 74.54(66.28-82.72) 55.65(51.26-59.89) 67.2 64.1 CRP 0.64 (0.56-0.72) 65.57(61.04-69.73) 46.78(41.75-51.83) 60.0 52.5 ESR 0.66 (0.59-0.74) 63.68(60.76-66.57) 52.28(44.65-59.83) 62.0 54.0 Osteomyelitis PCT 0.79 (0.72-0.85) 86.17(75.46-94.71) 45.37(39.94-50.73) 47.0 85.3 CRP 0.91 (0.86-0.95) 90.38(80.41-97.27) 57.04(49.08-68.46) 54.1 91.3 ESR 0.87 (0.82-0.92) 95.82(93.89-97.73) 50.08(42.32-57.86) 51.9 95.9 PAD PCT 0.73(0.64-0.82) 70.88(65.95-76.93) 71.76(69.19-74.17) 44.1 88.6 CRP 0.79(0.71-0.87) 83.36(78.81-87.89) 63.89(58.26-68.13) 42.1 92.4 ESR 0.81(0.73-0.88) 83.32(78.54-87.99) 52.08(47.82-57.19) 35.4 90.8 Data are calculated in cutoffs of 0.35 for PCT, 44.0 for CRP, and 61.5 for ESR. All data are presented with 95% confidence interval. PPV: positive predictive value; NPV: negative predictive value; AUC: area under the ROC curve. off values for PCT, ESR and CRP in predicting PAD were 0.45 (sensitivity of 70.8% and specificity of 71.7%), 61.5 (sensitivity of 83.3% and specificity of 52.0%) and 49 (sensitivity of 83.3% and specificity of 63.8%), respectively. 4. Discussion Based on the findings of the present study, although the ac- curacy of PCT, ESR and CRP in predicting the severity of di- abetic foot ulcers was fair, the increase of the three param- eters could predict the occurrence of osteomyelitis and PAD following diabetic food development with good accuracy and acceptable sensitivity. These three indicators seem to be beneficial in predicting wound infections rather than wound healing or classification. In the study by Korkmaz et al., the amount of CRP and ESR in patients with infectious ulcers was significantly higher than that of patients with non-infectious diabetic ulcers. Based on the analysis of the ROC curve, CRP had the highest capability for detecting infection, and the best cut-off point for CRP in predicting diabetic wound infec- tion was 28 (15). This cut point, however, was 44 in our study for assessing the severity of the wound itself. In the study by Park et al., PCT and CRP showed a high correlation with severity of diabetic ulcer infection, which was not consistent with our study. Also, PCT levels could be used to differentiate the existence of infection (16). This inconsistency can be due to the different methodology of our study as we were aiming to evaluate the general severity of wound, independent of in- fection, but in the Park et al. study, they have concentrated on the severity of wound infection rather than overall sever- ity. In the study by Massara et al., exploring the relationship be- tween these markers and the onset of diabetic foot ulcer, showed that PCT and CRP markers had the highest diagnos- tic values for predicting the incidence of diabetic foot ulcers (13). In the study by Victoria et al., the sensitivity and specificity of PCT in prediction of diabetic foot ulcer infection were 81% and 90%, respectively. However, other markers were not as- sociated with diabetic foot ulcer infection (17). In the study by Jonaidi et al. the best cutoff point, sensitivity and speci- ficity for CRP and PCT to distinguish infection in 30 patients were reported as 7.1 mg/dL, 80%, 74%, and 0.21, 70% and 74%, respectively (18). A possible explanation for the visible differences between their study and ours could be the limited number of individuals in our study population, affecting the power of the results. Several studies have been conducted on the relationship of increase in ESR and CRP with predicting osteomyelitis in di- abetic patients (19-21), but few studies have been done on the role of PCT in predicting osteomyelitis. Only in the study by Redman et al., the prominent role of PCT in periodonti- tis has been shown, which was shown to be even more po- tent than CRP (22). Also, there are few studies on the role of these markers in prediction of PAD occurrence. Increase in ESR and CRP was also associated with an increased risk of PAD occurrence (23). In general, due to the confirmation of the role of PCT, ESR and CRP indicators in predicting the occurrence of osteomyelitis and PAD complications follow- ing diabetic foot infection, the three indicators can be used to design and introduce scoring systems that determine the severity or development of related complications of diabetic foot ulcer. 5. Limitation Small sample size and unknown duration of ulcers and in- fections were among the limitations of the present study. All patients were hospitalized, so the ulcers were in PEDIS 3 and 4 stages. This open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0). Downloaded from: http://journals.sbmu.ac.ir/aaem 5 Archives of Academic Emergency Medicine. 2019; 7 (1): e37 6. Conclusion Although the role of PCT, ESR and CRP indices was not sig- nificant in predicting the severity of diabetic foot ulcer, the increase of the three parameters can predict the occurrence of two complications of osteomyelitis and PAD following the progression of diabetes with good accuracy and high sensi- tivity. 7. Appendix 7.1. Acknowledgements This article is extracted from the residency thesis of Hessam Amid in Infectious Diseases and Tropical Medicine program at Shahid Beheshti University of Medical Science, Tehran, Iran. 7.2. Author contribution All authors met the four criteria for authorship contribution based on recommendations of the International Committee of Medical Journal Editors. Authors ORCIDs Fahimeh Hadavand: 0000-0002-6565-1344 Atefeh Amouzegar: 0000-0003-3090-1662 Hessam Amid: 0000-0001-8552-154X 7.3. Funding/Support None. 7.4. Conflict of interest The authors have no conflict of interest. References 1. Wild S, Roglic G, Green A, Sicree R, King H. Global preva- lence of diabetes: estimates for the year 2000 and projec- tions for 2030. Diabetes care. 2004;27(5):1047-53. 2. Kalish J, Hamdan A. Management of diabetic foot prob- lems. Journal of vascular surgery. 2010;51(2):476-86. 3. HOSSEINI R, RASOULI A, Baradaran H. DIABETIC FOOT RISK FACTORS IN PATIENTS WITH DIABETES AT THE KAMKAR HOSPITAL DIABETES CLINIC IN QOM, IRAN 2008;25(4):21-6. 4. Yesil S, Akinci B, Yener S, Bayraktar F, Karabay O, Havit- cioglu H, et al. Predictors of amputation in diabetics with foot ulcer: single center experience in a large Turkish co- hort. Hormones. 2009;8(4):286-95. 5. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic re- view and meta-analysis. Clinical infectious diseases. 2004;39(2):206-17. 6. Assicot M, Bohuon C, Gendrel D, Raymond J, Carsin H, Guilbaud J. High serum procalcitonin concentra- tions in patients with sepsis and infection. The Lancet. 1993;341(8844):515-8. 7. Hammer S, Meisner F, Dirschedl P, Hobel G, Fraunberger P, Meiser B, et al. Procalcitonin: a new marker for di- agnosis of acute rejection and bacterial infection in pa- tients after heart and lung transplantation. Transplant immunology. 1998;6(4):235-41. 8. Kordek A, Podraza W, Czajka R. Reliability of semiquan- titative determination of procalcitonin serum concen- trations in neonates. Diagnostic microbiology and infec- tious disease. 2006;56(1):31-4. 9. Barati M, Eshaghi M, Noori N. EVALUATION OF CORRE- LATION BETWEEN ESR AND CRP WITH OSTEOMYLI- TIS IN DIABETIC FOOT. Razi Journal of Medical Sciences. 2003;10(33):9-15. 10. Armstrong DG, Perales TA, Murff RT, Edelson GW, Wel- chon JG. Value of white blood cell count with differential in the acute diabetic foot infection. Journal of the Ameri- can Podiatric Medical Association. 1996;86(5):224-7. 11. Jeandrot A, Richard J-L, Combescure C, Jourdan N, Finge S, Rodier M, et al. Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study. Di- abetologia. 2008;51(2):347-52. 12. Uzun G, Solmazgul E, Curuksulu H, Turhan V, Ardic N, Top C, et al. Procalcitonin as a diagnostic aid in dia- betic foot infections. The Tohoku journal of experimental medicine. 2007;213(4):305-12. 13. Massara M, De Caridi G, Serra R, Barilla D, Cutrupi A, Volpe A, et al. The role of procalcitonin as a marker of di- abetic foot ulcer infection. International wound journal. 2017;14(1):31-4. 14. Chuan F, Tang K, Jiang P, Zhou B, He X. Reliability and va- lidity of the perfusion, extent, depth, infection and sen- sation (PEDIS) classification system and score in patients with diabetic foot ulcer. PLoS One. 2015;10(4):e0124739. 15. Korkmaz P, Kocak H, Onbasi K, Bicici P, Ozmen A, Uyar C, et al. The Role of Serum Procalcitonin, Interleukin-6, and Fibrinogen Levels in Differential Diagnosis of Dia- betic Foot Ulcer Infection. Journal of diabetes research. 2018;20(2). 16. Park JH, Suh DH, Kim HJ, Lee YI, Kwak IH, Choi GW. Role of procalcitonin in infected diabetic foot ulcer. Diabetes research and clinical practice. 2017;128(4):51-7. 17. Aura Victoria van Asten S, Joseph Geradus Peters E, Xi Y, Alfred Lavery L. The role of biomarkers to diagnose di- abetic foot osteomyelitis. A meta-analysis. Current dia- betes reviews. 2016;12(4):396-402. This open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0). Downloaded from: http://journals.sbmu.ac.ir/aaem F. Hadavand et al. 6 18. Jafari NJ, Firouzabadi MS, Izadi M, Firouzabadi MSS, Saburi A. Can procalcitonin be an accurate diagnostic marker for the classification of diabetic foot ulcers? In- ternational journal of endocrinology and metabolism. 2014;12(1). 19. Sattar N, Hingorani AD. C-reactive protein and prognosis in diabetes: getting to the heart of the matter. Diabetes. 2009;58(4):798-9. 20. Wolfe F. The C-reactive protein but not erythrocyte sedi- mentation rate is associated with clinical severity in pa- tients with osteoarthritis of the knee or hip. The Journal of rheumatology. 1997;24(8):1486-8. 21. Van Asten SA, Nichols A, La Fontaine J, Bhavan K, Peters EJ, Lavery LA. The value of inflammatory markers to di- agnose and monitor diabetic foot osteomyelitis. Interna- tional wound journal. 2017;14(1):40-5. 22. Redman R, Kerr G, Payne JB, Mikuls TR, Huang J, Sayles H, et al. Salivary and serum procalcitonin and C- reactive protein as biomarkers of periodontitis in United States veterans with osteoarthritis or rheumatoid arthri- tis. Biotechnic & Histochemistry. 2016;91(2):77-85. 23. Garofolo L, Ferreira SRG, Miranda Junior F. Association between peripheral arterial disease and creactive protein in the japanese-brazilian population. Revista do Colegio Brasileiro de Cirurgioes. 2014;41(3):168-75. This open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0). Downloaded from: http://journals.sbmu.ac.ir/aaem Introduction Methods Results Discussion Limitation Conclusion Appendix References